Opinion|Videos|June 9, 2026

Long-Term VMS Management and Key Takeaways for Clinical Practice

In the final episode, "Long-Term VMS Management and Key Takeaways for Clinical Practice," the panelists explore the critical importance of viewing menopause management as a long-term, patient-centered endeavor rather than a time-limited intervention.

In the final episode, "Long-Term VMS Management and Key Takeaways for Clinical Practice," the panelists explore the critical importance of viewing menopause management as a long-term, patient-centered endeavor rather than a time-limited intervention. Drawing on SWAN data, the experts emphasize that VMS can begin two to twelve years before the final menstrual period and persist for years beyond it, with African American and Hispanic women often experiencing more severe and longer-lasting symptoms. They challenge the notion that treatment should be capped at an arbitrary duration — such as five years — noting that no evidence supports such restrictions, and that decisions about treatment duration should be driven by individual patient needs, risk profiles, and therapeutic goals rather than insurance guidelines or outdated assumptions rooted in WHI-era misinformation.

The experts also highlight that while hot flashes and night sweats may naturally diminish over time, other indications for continued therapy — such as osteoporosis prevention and sleep disturbance — may justify long-term treatment well into a patient's later years. They note that sleep disruption, particularly wake after sleep onset, remains a persistent challenge for many midlife women that warrants ongoing attention and management.

The episode closes with final reflections from both experts, who emphasize that the menopause treatment landscape has fundamentally shifted and that clinicians must evolve with it. They reinforce that a one-size-fits-all approach is insufficient, that barriers to care remain a significant challenge, and that the art of menopause medicine lies in creatively tailoring treatment to each individual patient. Both experts stress that even within the constraints of time-limited clinical visits, a series of shorter appointments can collectively deliver the comprehensive, prevention-focused care that every woman deserves.

Thank you for watching this Case-Based Peer Perspectives series on vasomotor symptoms in menopause. Please subscribe to our newsletter for information on upcoming video series.